Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ferrous sulfate 200mg/5ml oral liquid
0901011P0AABCBC
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 22.5mg/5ml oral solution
0901011P0AABTBT
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 240mg/5ml oral solution
0901011P0AABZBZ
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 250mg/5ml oral solution
0901011P0AABVBV
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 25mg/5ml oral solution
0901011P0AABIBI
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 300mg/5ml oral solution
0901011P0AABWBW
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 30mg/5ml oral solution
0901011P0AABRBR
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 325mg / Ascorbic acid 500mg MR tablets
0901011C0AAACAC
|
Generic tablet | Compound iron preparations | Nutrition and Blood | No data available |
|
Ferrous sulfate 40mg/5ml oral solution
0901011P0AACBCB
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 45mg/5ml oral solution
0901011P0AABHBH
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 500mg/5ml oral solution
0901011P0AACFCF
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 50mg/5ml oral solution
0901011P0AABBBB
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 580mg/5ml oral liquid
0901011P0AABEBE
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 65mg/5ml oral solution
0901011P0AACECE
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 75mg/5ml oral solution
0901011P0AABXBX
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 800mg/5ml oral solution
0901011P0AACGCG
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 80mg/5ml oral solution
0901011P0AACICI
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 90mg/5ml oral solution
0901011P0AABLBL
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate heptahydrate powder
190400000AAKAKA
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Fersamal 140mg/5ml syrup
0901011F0BCABAC
|
Fersamal | Ferrous fumarate | Nutrition and Blood | No data available |
|
Fersamal 210mg tablets
0901011F0BCAAAE
|
Fersamal | Ferrous fumarate | Nutrition and Blood | No data available |
|
Fertility ovulation thermometer
21040000100
|
Fertility ovulation thermometer | Contraceptive Devices | Appliances | No data available |
|
Ferumoxytol 510mg/17ml solution for infusion vials
0901012Q0AAAAAA
|
Ferumoxytol | Ferumoxytol | Nutrition and Blood | No data available |
|
Fetzima 40mg modified-release capsules
0403040AABBAAAA
|
Fetzima | Levomilnacipran | Central Nervous System | No data available |
|
Fetzima 80mg modified-release capsules
0403040AABBABAB
|
Fetzima | Levomilnacipran | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.